pimavanserin

FDA Drug Profile — pimavanserin

Drug Details

Generic Name
pimavanserin
Brand Names
pimavanserin
Application Number
ANDA214925
Sponsor
Novadoz Pharmaceuticals LLC
NDC Codes
1
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
PIMAVANSERIN TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE NUPLAZID ® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis [ see Clinical Studies (14) ] . NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ( 1 )